Opioid MisuseNCT06303804
Prevention of Opioid Misuse and Overdose Deaths Among Hispanic/Latinx Adolescents: A Family-based Perspective
A study testing Educational videos in people with Opioid Misuse, run by The University of Texas Health Science Center, Houston at 1 site in United States.
Trial summary
The purpose of this study is to develop culturally-competent family-focused educational modules targeting opioid knowledge and attitudes (including targeting safe storage and prevention of accidental opioid overdose in adolescent populations) and examine changes acceptability, knowledge, and attitudes scores Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Opioid Misuse
- What is being tested?
- Educational videos
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 6 participants
- Where
- 1 siteUnited States
- Study dates
- 6 Feb 2024to 21 Apr 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Must identify as Hispanic/Latino/a descent
- Have an adolescent between the ages of 15 and 17 years old living in their home a majority of the time
- Have English or Spanish proficiency
Who cannot join
- Adolescent or parent currently in opioid treatment
- Parent self-reports a substance use (including opioid use) disorder for themselves or adolescent
Trial locations and contacts
1 site in 1 country.
United States1 site
The University of Texas Health Science Center at Houston
Houston, Texas, 77030
About this study
The purpose of this study is to develop culturally-competent family-focused educational modules targeting opioid knowledge and attitudes (including targeting safe storage and prevention of accidental opioid overdose in adolescent populations) and examine changes acceptability, knowledge, and attitudes scores
- Conditions
- Opioid Misuse
- Being tested
- Educational videos
- Medical subject headings
- Opioid-Related Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Educational videosBehavioural
Participants will be delivered a link to complete demographic information and the initial assessment. Upon completing the (initial) pre-test knowledge assessment, participants will be sent links to the three educational videos staggered across 7 days. Educational videos will determine gaps in knowledge related to opioid use and overdose based on questionnaire responses. Upon the completion of the 7 days, participants will be sent a link to the (final) post-test knowledge assessment to complete.
| Study group | Role | What they receive |
|---|---|---|
| Educational videos arm | Experimental | Not described Receives: Behavioral: Educational videos |
What is being measured
The primary outcome is the main question the study is designed to answer.
Acceptability of the educational materials presented via the educational videos, including cultural congruence as assessed by a questionnaire
This questionnaire has 10 questions that is measured on a Likert scale from 1-4, higher number indicating more acceptability.
Measured: end of study (Day 7)
Changes in opioid related knowledge as assessed by a questionnaire
This has 3 subscales
- Brief Opioid Overdose Knowledge (BOOK) This has 12 questions and each is scored from 0(true), 1(false) for a maximum score of 12, higher score indicating more knowledge
- Opioid Overdose Knowledge Scale (OOKS) This has 9 questions, and participants have to identify all correct answers. Score ranges from 0(no correct answers) -33 (identified all correct answers) higher score indicates more knowledge
- Opioid Overdose Attitude Scale (OOAS)
This has 28 questions scored on a Likert scale from 1(completely disagree)-5(completely agree), higher number indicating more positive attitude
Measured: Baseline, end of study (Day 7)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Mar 2024
- Study start6 Feb 2024
- Primary completion21 Apr 2024
- Study completion21 Apr 2024
Why it stopped: PI left insitution
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Opioid MisuseStudies of the same condition, open and under way.
- More trials run by The University of Texas Health Science Center, HoustonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 6 participants (actual)
Sponsor and investigators
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Alejandra Fernandez, The University of Texas Health Science Center, Houston
- Investigators
- Alejandra Fernandez, PhD, Principal investigator, The University of Texas Health Science Center, Houston
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06303804
- Sponsor's protocol ID
- HSC-SPH-23-0837
- Status last verified
- Apr 2026
- First submitted
- 4 Mar 2024
- Last updated
- 7 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevention of Opioid Misuse and Overdose Deaths Among Hispanic/Latinx Adolescents: A Family-based Perspective
- ClinicalTrials.gov ID
- NCT06303804
- Acronym / sponsor ID
- HSC-SPH-23-0837
- Conditions
- Opioid Misuse
- Study type
- Interventional
- Recruitment status
- TerminatedReason stopped: PI left insitution
- Enrolment
- 6 participants (actual)
- Lead sponsor
- The University of Texas Health Science Center, HoustonUniversity, hospital or other
- Study start
- 6 Feb 2024 (actual)
- Primary completion
- 21 Apr 2024 (actual)
- Study completion
- 21 Apr 2024 (actual)
- First posted
- 12 Mar 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to develop culturally-competent family-focused educational modules targeting opioid knowledge and attitudes (including targeting safe storage and prevention of accidental opioid overdose in adolescent populations) and examine changes acceptability, knowledge, and attitudes scores
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Educational videos arm | Experimental | Behavioral: Educational videos |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Must identify as Hispanic/Latino/a descent
- Have an adolescent between the ages of 15 and 17 years old living in their home a majority of the time
- Have English or Spanish proficiency
Key exclusion criteria (2 listed)
- Adolescent or parent currently in opioid treatment
- Parent self-reports a substance use (including opioid use) disorder for themselves or adolescent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Educational videosParticipants will be delivered a link to complete demographic information and the initial assessment. Upon completing the (initial) pre-test knowledge assessment, participants will be sent links to the three educational videos staggered across 7 days. Educational videos will determine gaps in knowledge related to opioid use and overdose based on questionnaire responses. Upon the completion of the 7 days, participants will be sent a link to the (final) post-test knowledge assessment to complete. | Behavioural | Educational videos arm |
Primary outcome
Acceptability of the educational materials presented via the educational videos, including cultural congruence as assessed by a questionnaire
Time frame: end of study (Day 7)
This questionnaire has 10 questions that is measured on a Likert scale from 1-4, higher number indicating more acceptability.
Changes in opioid related knowledge as assessed by a questionnaire
Time frame: Baseline, end of study (Day 7)
This has 3 subscales 1. Brief Opioid Overdose Knowledge (BOOK) This has 12 questions and each is scored from 0(true), 1(false) for a maximum score of 12, higher score indicating more knowledge 2. Opioid Overdose Knowledge Scale (OOKS) This has 9 questions, and participants have to identify all correct answers. Score ranges from 0(no correct answers) -33 (identified all correct answers) higher score indicates more knowledge 3. Opioid Overdose Attitude Scale (OOAS) This has 28 questions scored on a Likert scale from 1(completely disagree)-5(completely agree), higher number indicating more positive attitude
Results and safety
The study was stopped early (reason given: PI left insitution). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Apr 2026.
- Individual participant dataSharing planned: No
Related trials for Opioid Misuse
Recruiting
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
Opioid Use Disorder, Opioid Misuse
Active, not recruitingPhase 3
Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial
Misuse, Opioid
Not yet recruitingObservational study
Disease Intervention Specialist (DIS) for SUD
Substance Use Disorder (SUD), Opioid Use Disorder
Active, not recruiting
Pain Self-Management and Treatment Engagement for Patients Taking Opioids
Chronic Pain, Opioid Use Disorder
Active, not recruiting
Healing Opioid Misuse and Pain Through Engagement (HOPE) Trial
Opioid Use Disorder, Chronic Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Alejandra Fernandez, PhD principal investigator
The University of Texas Health Science Center, Houston
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Educational videos in people with Opioid Misuse, run by The University of Texas Health Science Center, Houston at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 7 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: PI left insitution). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Acceptability of the educational materials presented via the educational videos, including cultural congruence as assessed by a questionnaire (time frame: end of study (Day 7)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Apr 2026.